United States · FDA National Drug Code directory
Propafenone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0832-0740_45afbac0-5c1a-ebc5-e063-6294a90a4d5e
- Product NDC
- 0832-0740
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Propafenone Hydrochloride
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200625 / 20261130
Source-listed ingredients
- PROPAFENONE HYDROCHLORIDE — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0740-60) · 0832-0740-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →